Kaydıhan Nuri, Alço Gül, Şenocak Mustafa Şükrü, Beşe Nuran
Department of Radiation Oncology (Resigned), İstanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty, İstanbul, Turkey.
Department of Radiation Oncology (In now), Memorial Bahçelievler Hospital, İstanbul, Turkey.
Eur J Breast Health. 2020 Dec 24;17(1):21-27. doi: 10.4274/ejbh.2020.5797. eCollection 2021 Jan.
To understand the clinical approach of radiation oncologists during the treatment of patients with breast reconstruction.
A questionnaire survey was emailed to 105 active members of the Turkish Radiation Oncology Society, the Breast Cancer Study Group. The factors associated with radiation oncologists and their current practice was identified.
Fifty radiation oncologists (47.6%) responded, and most of the responders (83%) were physicians who treated >50 new breast cancer patients annually. The majority of the physicians worked in academic hospitals and had more than 15 years of work experience. The early reconstruction rate was noted to be low among patients with mastectomy (<10% of the mastectomy patients) (p<0.05). Early implant irradiation with temporary tissue expander was noted to be a more common procedure. The majority of the respondents (68%) preferred to irradiate an inflated implant (20% total, 80% partial). In addition, 22% of the physicians declared that they routinely used bolus and that 60% of them used it only for patients at a high risk of local recurrence factors.
It can thus be concluded that variations exist between experienced radiation oncologists and others. Hypofractionation is not yet commonly practiced for patients with reconstruction in Turkey. A concrete consensus can be helpful to create a homogeneity in treatment decisions and practical applications.
了解放射肿瘤学家在乳腺癌重建患者治疗过程中的临床方法。
通过电子邮件向土耳其放射肿瘤学会乳腺癌研究组的105名活跃成员进行问卷调查。确定与放射肿瘤学家及其当前实践相关的因素。
50名放射肿瘤学家(47.6%)做出回应,大多数回应者(83%)是每年治疗超过50例新乳腺癌患者的医生。大多数医生在学术医院工作,并有超过15年的工作经验。乳房切除患者的早期重建率较低(乳房切除患者的<10%)(p<0.05)。早期使用临时组织扩张器进行植入物照射是一种更常见的程序。大多数受访者(68%)倾向于照射膨胀的植入物(20%全乳照射,80%部分照射)。此外,22%的医生宣称他们常规使用 bolus,其中60%仅在局部复发因素高危患者中使用。
因此可以得出结论,经验丰富的放射肿瘤学家与其他医生之间存在差异。在土耳其,对重建患者尚未普遍采用大分割放疗。具体的共识有助于在治疗决策和实际应用中形成一致性。